Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 53
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Eur J Clin Microbiol Infect Dis ; 28(5): 499-507, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19020910

RESUMO

Some genotypes of Acinetobacter baumannii, defined by pulsed-field gel electrophoresis (PFGE), have been found in many hospitals. Our aim was to find variable number tandem repeat (VNTR) loci capable of providing discrimination among isolates with highly similar or identical PFGE profiles, to gain insights into the epidemiology. Thirteen loci identified in A. baumannii ATCC 17978 were tested using a panel of isolates that included multiple representatives of genotypes belonging to the three European clonal lineages. Two loci, with repeat units of 9 and 6 bp respectively were selected. Repeat numbers varied between 3 and 29, and 9 and 26 respectively at the two loci. The repeat numbers of representatives of each genotype often differed between hospitals, providing a means of tracking patient transfers and possible transmissions between patients. The results suggest that this analysis accurately reflects the known epidemiological information, and provides a valuable tool for cross-infection studies.


Assuntos
Acinetobacter baumannii/classificação , Acinetobacter baumannii/genética , Técnicas de Tipagem Bacteriana , Impressões Digitais de DNA/métodos , DNA Bacteriano/genética , Repetições Minissatélites , Eletroforese em Gel de Campo Pulsado , Genótipo , Humanos , Epidemiologia Molecular/métodos , Sensibilidade e Especificidade
2.
Clin Microbiol Infect ; 13(8): 807-15, 2007 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17610600

RESUMO

Representatives (n = 31) of outbreak strains of Acinetobacter baumannii from five countries fell into three clear groups, designated Groups 1-3, based on their ompA (outer-membrane protein A), csuE (part of a pilus assembly system required for biofilm formation) and bla(OXA-51-like) (the intrinsic carbapenemase gene in A. baumannii) gene sequences. With the exception of the closely related alleles within the Group 1 clonal complex, alleles at each locus were highly distinct from each other, with a minimum of 14 nucleotide differences between any two alleles. Isolates within a group shared the same combination of alleles at the three loci, providing compelling evidence that the outbreak strains investigated belonged to three clonal lineages. These corresponded to the previously identified European clones I-III. Sequence differences among the alleles were used to design multiplex PCRs to rapidly assign isolates belonging to particular genotypes to sequence groups. In the UK, genotypes belonging to the Group 1 clonal complex have been particularly successful, accounting for the vast majority of isolates referred from hospitals experiencing problems with Acinetobacter.


Assuntos
Infecções por Acinetobacter/genética , Acinetobacter baumannii , Infecção Hospitalar/genética , Surtos de Doenças/classificação , Infecções por Acinetobacter/classificação , Infecções por Acinetobacter/epidemiologia , Acinetobacter baumannii/classificação , Acinetobacter baumannii/genética , Acinetobacter baumannii/patogenicidade , Infecção Hospitalar/microbiologia , Eletroforese em Gel de Campo Pulsado , Europa (Continente)/epidemiologia , Humanos , Israel/epidemiologia , Dados de Sequência Molecular , Filogenia , Reação em Cadeia da Polimerase , Estudos Retrospectivos
3.
J Hosp Infect ; 64(2): 115-23, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16859810

RESUMO

Information on risk factors for acquisition of extended-spectrum ss-lactamase (ESBL)-producing organisms and their outcomes in patients with invasive infections is scant. The objectives of this study were to evaluate risk factors and all-cause mortality associated with infection due to ESBL-producing organisms using a nested case-control design, and to document transmission within a hospital employing molecular and conventional epidemiological methods. From December 2003 to April 2005, 50 patients with bloodstream infections (BSIs) due to ESBL-producing E. coli and Klebsiella spp. were recruited. Controls (N=50) were chosen, within the same period, from patients with non-ESBL-producing BSIs by simple random sampling; account was taken of potential confounding factors. Cases and controls were followed-up until November 2005, and outcomes were recorded as discharged or deceased. Molecular methods, supported by conventional epidemiology, were used to study the transmission of organisms. Logistic regression analyses showed prior ss-lactam antibiotics [odds ratio (OR) 11.57; 95% confidence intervals (CI) 2.31-51.15; P=0.003], hospital stay >15 days (OR 2.63; 95% CI 1.01-6.89; P=0.04) and prior admission to the intensive care unit (OR 13.98; 95% CI 1.88-19.15; P=0.006) to be independent risk factors for the acquisition of ESBL-producing organisms. In the first 15 days of follow-up, a significant proportion of patients with ESBL-producing organisms died; however, there was no difference in mortality between cases and controls at the end of the follow-up period. Molecular epidemiology identified five clusters amongst the ESBL-producing isolates. Conventional epidemiological analyses supported the evidence of transmission in three of these clusters.


Assuntos
Infecção Hospitalar/epidemiologia , Infecções por Escherichia coli/epidemiologia , Controle de Infecções , Infecções por Klebsiella/epidemiologia , Adolescente , Adulto , Estudos de Casos e Controles , Criança , Pré-Escolar , Infecção Hospitalar/etiologia , Infecção Hospitalar/mortalidade , Infecção Hospitalar/prevenção & controle , DNA Bacteriano/análise , Escherichia coli/genética , Escherichia coli/isolamento & purificação , Escherichia coli/metabolismo , Infecções por Escherichia coli/etiologia , Infecções por Escherichia coli/mortalidade , Infecções por Escherichia coli/prevenção & controle , Feminino , Hospitais Comunitários , Humanos , Lactente , Klebsiella/genética , Klebsiella/isolamento & purificação , Klebsiella/metabolismo , Infecções por Klebsiella/etiologia , Infecções por Klebsiella/mortalidade , Infecções por Klebsiella/prevenção & controle , Londres/epidemiologia , Masculino , Pessoa de Meia-Idade , Avaliação de Resultados em Cuidados de Saúde , Fatores de Risco , Análise de Sobrevida , Resistência beta-Lactâmica , beta-Lactamases/metabolismo
4.
J Hosp Infect ; 64(2): 124-8, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16899327

RESUMO

This paper describes an outbreak of postoperative sternal wound infections. A cardiac surgeon noted a cluster of serious infections leading to wound dehiscence, despite the fact that none of his colleagues had noticed a rise in infection rates. The infections were predominantly with Enterobacter cloacae, and molecular typing and serotyping showed these isolates to be indistinguishable. Observation of the surgeon's practice revealed nothing untoward, and there were no infections among his patients operated on in another hospital. There appeared to be no significant difference between the modes of operation of the different surgeons. The operating theatres were screened to exclude an environmental source, with samples cultured on CHROMagar Orientation, a selective/differential medium designed for urine samples. Further questioning revealed one difference between the practices of the different surgeons; this surgeon used semi-frozen Hartmann's solution to achieve cardioplegia. The freezer used for this was swabbed and yielded E. cloacae, indistinguishable from the clinical isolates. It is hypothesized that this organism contaminated the freezer, and that the contamination was passed on to the ice/slush solution, thus infecting the patients. There have been no more cases since the freezer was replaced, a rigorous cleaning schedule instituted, and steps taken to reduce the possibility of any further contamination.


Assuntos
Infecção Hospitalar/epidemiologia , Surtos de Doenças , Infecções por Enterobacteriaceae/epidemiologia , Infecção da Ferida Cirúrgica/epidemiologia , Procedimentos Cirúrgicos Cardiovasculares/efeitos adversos , Infecção Hospitalar/etiologia , Infecção Hospitalar/prevenção & controle , DNA Bacteriano/análise , Enterobacter cloacae/genética , Enterobacter cloacae/isolamento & purificação , Infecções por Enterobacteriaceae/etiologia , Infecções por Enterobacteriaceae/prevenção & controle , Unidades Hospitalares , Humanos , Controle de Infecções , Londres/epidemiologia , Complicações Pós-Operatórias , Esterno , Infecção da Ferida Cirúrgica/etiologia , Infecção da Ferida Cirúrgica/prevenção & controle
5.
Cancer Res ; 48(9): 2335-41, 1988 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-3356001

RESUMO

Platinum rhodamine 123 [Pt(Rh-123)2] was synthesized in an effort to produce a new drug which would have the selective uptake into carcinoma cells of Rh-123 and the alkylating and radiosensitizing properties of the chloroplatinum moiety. Because both Rh-123 and cis-diamminedichloroplatinum(II) (CDDP) have been shown to become more cytotoxic at elevated temperatures, we tested the interactions between Pt(Rh-123)2 and hyperthermia both in EMT6 cells in vitro and in the Lewis lung carcinoma in vivo. In the EMT6 cells, CDDP was far more cytotoxic than Pt(Rh-123)2 at 37 degrees C, but its cytotoxicity was less enhanced by exposure of cells to the drug at 42 degrees C than was true for Pt(Rh-123)2 [about 2 logs of increased killing at 42 degrees C after exposure to 10 microM CDDP versus over 3 logs of increased killing at 42 degrees C after exposure to 500 microM Pt(Rh-123)2]. Both Rh-123 and K2PtCl4 also are more cytotoxic to EMT6 cells at 42 degrees C than at 37 degrees C, but the hyperthermic enhancement was far less striking. In the Lewis lung carcinoma, the growth delay produced by CDDP (8 mg/kg) increased by a factor of approximately 2.5 when the drug was given i.p. just prior to local heating of the s.c. thigh tumor to 43 degrees C for 30 min, but the growth delay produced by Pt(Rh-123)2 (100 mg/kg) given i.p. 1 h before local hyperthermia increased by a factor of 5. In contrast, K2PtCl4 and Rh-123 given i.p. produced very short growth delays at normal temperatures and these growth delays were not enhanced by hyperthermia. The effect of these drugs at 37 degrees C and 42 degrees C on the conformation of superhelical pBR322 DNA was also examined. Exposure to CDDP caused progressive alteration from the supercoiled to the linear form of the DNA over time. In contrast, Pt(Rh-123)2 apparently produced progressive degradation of the DNA. Hyperthermia did not alter the qualitative damage produced by the drugs but increased the rate at which the changes occurred. These results suggest both that Pt(Rh-123)2 probably has a different mechanism of action at the DNA than does CDDP and that Pt(Rh-123)2 may be a good drug to use with local hyperthermia and radiation.


Assuntos
Antineoplásicos/farmacologia , Cloretos/farmacologia , Cisplatino/farmacologia , Temperatura Alta , Compostos Organoplatínicos/farmacologia , Compostos de Platina , Platina/farmacologia , Rodaminas/farmacologia , Xantenos/farmacologia , Animais , Sobrevivência Celular/efeitos dos fármacos , Dano ao DNA , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Neoplasias Experimentais/terapia , Conformação de Ácido Nucleico , Rodamina 123 , Células Tumorais Cultivadas/efeitos dos fármacos
6.
Cancer Res ; 48(18): 5101-5, 1988 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-3409235

RESUMO

The effect of concomitant hyperthermia on the cytotoxicities of cis-diamminedichloroplatinum(II) (CDDP), a newly synthesized drug, Pt(Rh-123)2, and its chemical components, K2PtCl4 and rhodamine 123, was examined in vitro in a squamous cell tumor line of human origin (SCC-25) and in a CDDP-resistant subline (SCC-25/CP). No difference in the cytotoxicity of hyperthermia alone was observed between these cell lines. The dose-dependent cytotoxicities of 1-h exposures to CDDP and Pt(Rh-123)2 were markedly increased at 42 degrees C and 43 degrees C in comparison to 37 degrees C, and this effect was of the same magnitude in both cell lines (enhancements of approximately 1.5 logs at 42 degrees C and 2.5 logs at 43 degrees C for CDDP and 1.5 logs at 42 degrees C and greater than 3 logs at 43 degrees C for Pt(Rh-123)2). The use of hyperthermia with CDDP, however, did not lower survivals in the SCC-25/CP cells even to the levels seen in the parent line at 37 degrees C. The cytotoxicities of K2PtCl4 and rhodamine 123 were essentially the same in the CDDP-sensitive and -resistant cells at all temperatures tested. The magnitude of the temperature effect was significantly greater for Pt(Rh-123)2 than for its chemical components. No significant effect on CDDP or Pt(Rh-123)2 accumulation was observed at 42, 43, 44 or 45 degrees C in either cell line. DNA lesions, measured by alkaline elution, were significantly enhanced for CDDP in the SCC-25 cells at 42 degrees C. These results suggest that treatment with hyperthermia and either CDDP or Pt(Rh-123)2 should result in supraadditive anti-tumor effects, although the efficacy of CDDP plus hyperthermia will be significantly less once resistance to CDDP has developed. Since resistance to CDDP does not imply cross-resistance to Pt(Rh-123)2, and since the effect of hyperthermia is somewhat greater for Pt(Rh-123)2 than for CDDP at 43 degrees C, Pt(Rh-123)2 may be more selectively toxic to tumor cells when used with local hyperthermia versus normal cells outside the treated area, especially if resistance to CDDP has already developed.


Assuntos
Carcinoma de Células Escamosas/patologia , Cisplatino/farmacologia , Hipertermia Induzida , Compostos Organometálicos/farmacologia , Compostos Organoplatínicos , Sobrevivência Celular/efeitos dos fármacos , Resistência a Medicamentos , Neoplasias de Cabeça e Pescoço/patologia , Humanos , Rodamina 123 , Rodaminas/farmacologia
7.
AIDS ; 12(14): 1771-5, 1998 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-9792377

RESUMO

OBJECTIVES: To establish the clinical pattern of Pseudomonas aeruginosa respiratory infections in HIV-seropositive patients and to determine whether repeated isolation of the organism represents reinfection or recurrence and to assess whether common source, nosocomial infection occurred. DESIGN AND METHODS: Evaluation of the clinical pattern of P. aeruginosa respiratory infections by case note review and epidemiological characterization of P. aeruginosa by serotype determination and Xbal DNA macrorestriction analysis. Serum sensitivity testing of strains was performed to further define phenotypic characteristics of the isolated organisms. RESULTS: Seventy-three per cent (29 out of 40) of individuals had P. aeruginosa isolated on two or more occasions in the setting of clinical respiratory infection. Overall, 85% had evidence of P. aeruginosa to within 2 months of study completion or death. Epidemiological characterization revealed persistence of unique single strains in 93% of individuals where multiple isolates were available for testing, whereas only two patients harboured a common strain. The serotype distribution of strains was similar to that reported from non-HIV-positive patients. CONCLUSIONS: Once established, eradication of P. aeruginosa from the respiratory tract of HIV-seropositive individuals with advanced immunosuppression is problematic and a chronic infective state appears common. There was no evidence of nosocomial transmission. Serotype loss and development of sensitivity to normal human serum were both observed and were highly correlated. This represents truncation of O-antigenic lipopolysaccharide on the cell surface of P. aeruginosa and may reflect progression to phenotypes commonly associated with chronic infection in other clinical settings such as cystic fibrosis.


Assuntos
Síndrome da Imunodeficiência Adquirida/complicações , Infecções por Pseudomonas/microbiologia , Pseudomonas aeruginosa/isolamento & purificação , Infecções Respiratórias/microbiologia , Adulto , Atividade Bactericida do Sangue , Impressões Digitais de DNA , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Infecções por Pseudomonas/complicações , Infecções por Pseudomonas/epidemiologia , Pseudomonas aeruginosa/classificação , Pseudomonas aeruginosa/imunologia , Infecções Respiratórias/complicações , Sorotipagem , Escarro/microbiologia
8.
APMIS ; 101(11): 838-44, 1993 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7506916

RESUMO

The purpose of this study was to make an independent evaluation of the methods of bio-, phage-, and O-serotyping which had been used only in the laboratory of origin, and to assess the extent of possible cross-infection of Enterobacter cloacae in a Danish university hospital. The material consisted of 237 clinical isolates of E. cloacae from the clinical microbiology laboratory at Hvidovre Hospital. The typability of bio-, phage-, and serotyping was 100%, 83%, and 85%, respectively. Reproducibility of serotyping was 90% and of phage typing 96% if two major differences were allowed to differentiate between patterns. O-serotyping had the highest discriminatory power and combination of all typing methods further increased discrimination. Outbreaks of E. cloacae were not evident in clinical departments, but cross-infections from one department to another could not be completely ruled out. We concluded that the combination of bio-, phage- and O-serotyping is sufficiently discriminating and will be satisfactory in the majority of clinical situations.


Assuntos
Enterobacter cloacae/classificação , Infecções por Enterobacteriaceae/microbiologia , Tipagem de Bacteriófagos , Bacteriófagos , Infecção Hospitalar/diagnóstico , Humanos , Lipopolissacarídeos/imunologia , Antígenos O , Polissacarídeos Bacterianos/análise , Sorotipagem
9.
Infect Control Hosp Epidemiol ; 21(12): 786-9, 2000 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-11140915

RESUMO

Among 145 Enterococcus faecalis isolates recovered during a 15-month period (April 1997-June 1998) in AHEPA University Hospital, Thessaloniki, Greece, 94 (65%) exhibited high-level resistance to gentamicin or streptomycin and 61 (42%) to both aminoglycosides; 73% of the high-level aminoglycoside-resistant E. faecalis isolates belonged to a single clone carrying the gene aac(6')-Ie-aph(2")-Ia. These findings differ from those of other regions, where high-level aminoglycoside-resistance genes are dispersed into genetically unrelated strains.


Assuntos
Antibacterianos/farmacologia , Surtos de Doenças , Enterococcus faecalis/patogenicidade , Aminoglicosídeos , Infecção Hospitalar , DNA Bacteriano/análise , Resistência Microbiana a Medicamentos , Eletroforese em Gel de Campo Pulsado , Enterococcus faecalis/efeitos dos fármacos , Enterococcus faecalis/genética , Grécia/epidemiologia , Hospitais Universitários , Humanos
10.
Infect Control Hosp Epidemiol ; 18(7): 510-2, 1997 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9247836

RESUMO

We describe an apparent outbreak of respiratory infection with Acinetobacter species involving 14 patients over 8 days. Epidemiological investigation revealed two consecutive pseudo-outbreaks of infection caused by two consecutive, unrelated laboratory errors in the processing of sputum, nasopharyngeal, and endotracheal aspirates.


Assuntos
Infecções por Acinetobacter/transmissão , Acinetobacter/isolamento & purificação , Infecção Hospitalar/transmissão , Infecções Respiratórias/transmissão , Manejo de Espécimes , Infecções por Acinetobacter/epidemiologia , Técnicas de Laboratório Clínico/instrumentação , Infecção Hospitalar/epidemiologia , Eletroforese em Gel de Campo Pulsado , Contaminação de Equipamentos , Humanos , Infecções Respiratórias/epidemiologia
11.
Radiat Res ; 121(2): 187-95, 1990 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2305037

RESUMO

Complexes of the platinum(II) tetrachlorodianion with positively charged nuclear dyes have been prepared in an effort to produce neutral molecules which could gain ready access to the nuclear DNA where the platinum(II) tetrachlorodianion could function as a radiosensitizing and a bifunctional alkylating agent. The thiazin dyes Thionin, Azure B, and Methylene Blue, the aminoxanthene dye Pyronin Y, and the thiazole dye Thioflavin have each been complexed to the platinum(II) tetrachlorodianion(PtCl4) in a ratio of 2:1(dye:PtCl4). Studies of the interaction of these complexes and of the dyes with the pBR322 plasmid superhelical DNA demonstrated that while each complex and dye readily associated with the DNA in a dose-dependent manner, only Pt(Thioflavin)2 and Thioflavin produced irreversible DNA changes (single-strand breaks). In exponentially growing EMT6 cells the cytotoxicity of these drugs was assessed in normally oxygenated and hypoxic cells at both pH 7.4 and 6.45. At concentrations ranging from 1 to 500 microM, Pt(Methylene Blue)2 was significantly more cytotoxic than the other thiazin dye complexes Pt(Thionin)2 and Pt(Azure B)2. The cytotoxicity of Pt(Thionin)2 and Pt(Methylene Blue)2 was increased in normally oxygenated and hypoxic cells at low pH. Both Pt(Pyronin Y)2 and Pt(Thioflavin)2 were more toxic than the thiazin complexes. Pt(Pyronin Y)2 was most cytotoxic to normally oxygenated cells at normal pH and hypoxic cells at low pH, while Pt(Thioflavin)2 was most cytotoxic to cells at low pH under both oxygenation conditions. In vitro studies of the radiosensitizing properties of these agents in EMT6 cells demonstrated that exposure to 100 microM for 1 h before and during irradiation (except for Pt[Thioflavin]2, which was assayed at 25 microM) resulted in enhancement rations of 2.5, 1.9, 1.5, and 1.5 for Pt(Azure B)2, Pt(Thionin)2, Pt(Pyronin Y)2, and Pt(Thioflavin)2, respectively, in hypoxic cells. In contrast, Pt(Methylene Blue)2 (and Methylene Blue) proved to be a radioprotector of normally oxygenated cells and did not sensitize hypoxic cells to the cytotoxic effects of radiation. In the FSaIIC fibrosarcoma in vivo administration of each drug at 100 mg/kg intraperitoneally (ip) 15 min prior to irradiation (except for Pt[Thioflavin]2, which was given at 1 mg/kg ip) showed that, with single radiation fractions of 10 and 20 Gy, dose-modifying factors of 2.1, 1.8, 1.5, and 1.2 were produced by Pt(Azure B)2, Pt(Thionin)2, Pt(Pyronin Y), and Pt(Methylene Blue)2, respectively, after correcting for growth delays induced by the drug alone. In comparison, misonidazole at 1 g/kg ip produced a dose-modifying factor of 1.4.(ABSTRACT TRUNCATED AT 400 WORDS)


Assuntos
Antineoplásicos/farmacologia , Corantes/farmacologia , DNA de Neoplasias/efeitos dos fármacos , Compostos Organoplatínicos/farmacologia , Radiossensibilizantes/farmacologia , Tiazinas/farmacologia , Xantenos/farmacologia , Animais , Antineoplásicos/uso terapêutico , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Corantes/uso terapêutico , Técnicas In Vitro , Masculino , Camundongos , Camundongos Endogâmicos C3H , Transplante de Neoplasias , Neoplasias Experimentais/tratamento farmacológico , Compostos Organoplatínicos/uso terapêutico , Radiossensibilizantes/uso terapêutico , Tiazinas/uso terapêutico , Células Tumorais Cultivadas/efeitos dos fármacos , Xantenos/uso terapêutico
12.
Radiat Res ; 119(1): 134-44, 1989 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-2756104

RESUMO

A new complex of tetrachloroplatinum(II) and the azoic diazo dye, Fast Black K, Pt(Fast Black)2, was made in an attempt to produce an uncharged molecule which could readily gain access into cells and could bring a high concentration of tetrachloroplatinum into the vicinity of the DNA. Even the lowest concentration of Pt(Fast Black)2 tested in the superhelical pBR322 plasmid DNA assay in vitro completely converted the superhelical DNA to the circular and linear forms by 24 h. When the cytotoxicity of the Pt(Fast Black)2 and Fast Black were tested in exponentially growing EMT6 cells. Pt(Fast Black)2 was slightly more toxic to normally oxygenated than to hypoxic cells at pH 7.40, but was far more toxic to cells at pH 6.45 with no difference based on cellular oxygenation. Fast Black was much less toxic than Pt(Fast Black)2 and its cytotoxicity was unaffected by pH. Pt(Fast Black)2 had a small radiosensitizing effect on hypoxic EMT6 cells with a dose-modifying factor of 1.3, but exposure to the drug entirely removed the shoulder region on the radiation survival curves for both the oxygenated and hypoxic cells. In contrast, Fast Black reduced the shoulder in hypoxic but not in oxygenated cells. When Pt(Fast Black)2 (500 mg/kg), Fast Black (300 mg/kg) (the maximally tolerated dose), or misonidazole (1 g/kg) were given intraperitoneally 15 min prior to irradiation of FSaIIC tumors with 0, 10, 20, or 30 Gy, Pt(Fast Black)2 alone caused a tumor growth delay of 6 days versus 3 days for Fast Black. With radiation, Pt(Fast Black)2 produced the greatest enhancement in tumor growth delay of the drugs tested, especially at the lowest (10 Gy) radiation dose (i.e., in the in vivo "shoulder region"). These results indicate that Pt(Fast Black)2 may be suitable for clinical development because it causes both significant direct cytotoxicity and enhancement of radiation killing. The fact that its cytotoxicity is markedly increased at an acidic pH and its radiation enhancing effects are greatest in combination with relatively low single-fraction radiation doses make it especially interesting. The cytotoxicity of Pt(Fast Black)2 may be influenced by the tumor environment, and the radiosensitizing properties appear well suited for use with radiation fraction sizes that are employed in the clinic.


Assuntos
Sobrevivência Celular/efeitos dos fármacos , DNA Super-Helicoidal/efeitos dos fármacos , Compostos de Diazônio/farmacologia , Neoplasias Experimentais/tratamento farmacológico , Compostos Organoplatínicos/farmacologia , Animais , Sobrevivência Celular/efeitos da radiação , Compostos de Diazônio/síntese química , Compostos de Diazônio/uso terapêutico , Masculino , Camundongos , Camundongos Endogâmicos C3H , Transplante de Neoplasias , Neoplasias Experimentais/radioterapia , Compostos Organoplatínicos/síntese química , Compostos Organoplatínicos/uso terapêutico
13.
Radiat Res ; 120(1): 129-39, 1989 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-2798776

RESUMO

Complexes of the positively charged, nuclear staining, quinone-imine dyes Nile Blue and Neutral Red with negatively charged tetrachloroplatinum (II) have been prepared in an effort to form neutral drugs which could gain ready access to the cellular nucleus and deliver significant quantities of the reactive tetrachloroplatinum anion to the vicinity of the DNA. Elemental analysis showed that both the Nile Blue and Neutral Red complexes with tetrachloroplatinum (II) comprised 2 mol of dye and 1 mol of tetrachloroplatinum, forming Pt(Nile Blue)2 and Pt(Neutral Red)2. Exposure of superhelical pBR322 DNA to the complexes or the dyes for 24 h followed by agarose gel electrophoresis showed that Neutral Red and Pt(Neutral Red)2 had little effect on DNA conformation, but that both Nile Blue and Pt(Nile Blue)2 could produce single-strand DNA breaks in a dose-dependent fashion. Studies in exponentially growing asynchronous, hypoxic, and normally oxygenated EMT6 cells at normal pH (7.40) and pH 6.45 demonstrated that neither dye was highly toxic, but that both complexes were capable of producing significant cytotoxicity. Both complexes killed normally oxygenated cells more efficiently than hypoxic cells, but Pt(Neutral Red)2 was more cytotoxic at pH 6.45, while Pt(Nile Blue)2 killed significantly more cells at normal pH. Both complexes decreased the survival of hypoxic EMT6 cells as indicated by the slope of the radiation survival curve [dose modifying factor (DMF) 2.90 for Pt(Nile Blue)2 and 1.45 for Pt(Neutral Red)2]. Studies with the FSaIIC murine tumor showed that both complexes were active radiosensitizing agents in vivo [DMF 1.76 for Pt(Nile Blue)2 and 1.25 for Pt(Neutral Red)2]. These results indicate that these new platinum complexes have characteristics which may make them and similar complexes effective radiosensitizing agents in humans.


Assuntos
DNA Super-Helicoidal/efeitos dos fármacos , Vermelho Neutro/farmacologia , Oxazinas/farmacologia , Fenazinas/farmacologia , Platina/farmacologia , Radiossensibilizantes/farmacologia , Animais , Hipóxia Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Terapia Combinada , Dano ao DNA , DNA de Cadeia Simples/efeitos da radiação , Masculino , Camundongos , Camundongos Endogâmicos C3H , Transplante de Neoplasias , Neoplasias Experimentais/tratamento farmacológico , Neoplasias Experimentais/radioterapia , Conformação de Ácido Nucleico/efeitos dos fármacos , Radiossensibilizantes/uso terapêutico
14.
J Clin Pathol ; 52(3): 173-6, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10450174

RESUMO

AIMS: To evaluate three oligonucleotide primer pairs--two specific for 16S and 23S rRNA sequences of Burkholderia cepacia, and the third specific for internal transcribed spacer region of 16S-23S sequences of B gladioli--for the identification and differentiation of reference and clinical strains of these and other species. METHODS: The three primers sets were applied in polymerase chain reaction (PCR) to a collection of 177 clinical isolates submitted for identification from diagnostic laboratories as presumed B cepacia. RESULTS: At an annealing temperature of 63 degrees C, all eight B cepacia and four B gladioli reference strains reacted with their specific primers. B vandii was the only other species that was positive with both B cepacia primers but five Burkholderia or Ralstonia species reacted with one of these primers. Seventy eight isolates were typical of B cepacia in biochemical tests and 75 of these reacted with specific primers; three, however, were positive with the B gladioli primers. Fifteen asaccharolytic isolates were confirmed as B cepacia by PCR but other non-fermenting Gram negative species were negative with each of the primers. CONCLUSIONS: PCR using 16S rRNA sequences is recommended for identification of B cepacia that give atypical results in biochemical tests.


Assuntos
Infecções por Burkholderia/diagnóstico , Burkholderia cepacia/genética , Fibrose Cística/microbiologia , Burkholderia/genética , Infecções por Burkholderia/microbiologia , Primers do DNA , Estudos de Avaliação como Assunto , Humanos , Reação em Cadeia da Polimerase/métodos , RNA Bacteriano/genética , RNA Ribossômico 16S/genética , RNA Ribossômico 23S/genética , Sensibilidade e Especificidade
15.
J Med Microbiol ; 40(6): 403-7, 1994 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-8006932

RESUMO

Three consecutive isolates of Enterobacter aerogenes were obtained from the blood cultures of a hospitalised patient who was receiving antibiotic therapy. The initial isolate possessed an inducible cephalosporinase and was susceptible to third-generation cephalosporins. After ceftazidime treatment, a second isolate resistant to this antibiotic and characterised by stable overproduction of the chromosomal beta-lactamase was obtained, and therapy was altered to a new combination which included imipenem. During this course of treatment, a strain of E. aerogenes was isolated that was resistant to virtually all beta-lactam agents including imipenem. Comparison of biotypes and ribotyping profiles indicated that the three isolates were probably derived from a single strain which had undergone several mutations during antibiotic exposure. Examination of outer-membrane protein (OMP) preparations and lipopolysaccharide (LPS) profiles showed that the imipenem-resistant isolate lacked a major OMP and high molecular mass LPS. Furthermore, this isolate displayed reduced permeability to cephaloridine compared with the initial isolate. The introduction of a plasmid carrying a wild-type ampD allele prevented cephalosporinase production and restored beta-lactam susceptibility in the imipenem-resistant isolate. It was concluded that stable derepression of class-I beta-lactamase production and reduced permeability are both required for expression of imipenem resistance in E. aerogenes, and that previous exposure to cephalosporins may encourage the emergence of such strains.


Assuntos
Enterobacter/genética , Infecções por Enterobacteriaceae/microbiologia , Imipenem/farmacologia , Mutação , Idoso , Proteínas da Membrana Bacteriana Externa/análise , Permeabilidade da Membrana Celular , Cefalosporinas/farmacologia , Cefalosporinas/uso terapêutico , Resistência Microbiana a Medicamentos/genética , Enterobacter/classificação , Enterobacter/efeitos dos fármacos , Infecções por Enterobacteriaceae/tratamento farmacológico , Humanos , Imipenem/uso terapêutico , beta-Lactamases/biossíntese
16.
J Med Microbiol ; 50(8): 682-687, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11478671

RESUMO

Ten glycopeptide-resistant Enterococcus faecium isolates from separate patients in Laikon General Hospital, Athens were studied. Eight isolates had the VanA phenotype and represented variants of three strains based on SmaI macrorestriction banding patterns. Their VanA elements were compared with the prototype element, Tn1546, by an overlapping PCR method. Three related isolates contained resistance elements indistinguishable from Tn1546 (designated Greek type I). The other five isolates all contained identical elements that differed from Tn1546 by the presence of IS1251 between vanS and vanH, by a point mutation (G --> T) at nucleotide position 8234 within vanX and by a partial loss of transposition gene orf1 (designated Greek type II). Two distinct strains of E. faecium with the VanB phenotype were obtained. HhaI digestion of an amplified fragment of the vanB gene indicated that both strains contained the vanB2 allele, and further PCR assays confirmed that the vanB2 gene cluster was located within a Tn5382-like element.


Assuntos
Antibacterianos/farmacologia , Proteínas de Bactérias/genética , Carbono-Oxigênio Ligases/genética , Enterococcus faecium/genética , Alelos , Proteínas de Bactérias/classificação , Carbono-Oxigênio Ligases/classificação , Desoxirribonucleases de Sítio Específico do Tipo II , Resistência Microbiana a Medicamentos/genética , Eletroforese em Gel de Campo Pulsado , Enterococcus faecium/efeitos dos fármacos , Enterococcus faecium/isolamento & purificação , Amplificação de Genes , Genótipo , Grécia , Humanos , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular , Família Multigênica , Fenótipo , Mutação Puntual , Reação em Cadeia da Polimerase , Polimorfismo de Fragmento de Restrição , Reto/microbiologia , Teicoplanina/farmacologia , Resistência a Vancomicina/genética
17.
J Med Microbiol ; 49(4): 367-370, 2000 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-10755632

RESUMO

Coagulase-negative staphylococcal bacteraemia in immunocompromised patients is often associated with the use of central venous catheters, while the proposed origin of viridans streptococci causing bacteraemia in this patient group is the oral cavity. This report describes an episode of polymicrobial bacteraemia caused by Staphylococcus epidermidis and Streptococcus oralis followed by several further episodes of S. epidermidis bacteraemia in a 15-year-old boy after bone marrow transplantation. Pulsed-field gel electrophoresis (PFGE) of SmaI chromosomal DNA digests was used to compare blood culture and oral isolates of S. epidermidis and Str. oralis. The results indicated that the mouth was the source of both S. epidermidis and Str. oralis causing the first episode of bacteraemia. PFGE further demonstrated that the central venous catheter was the origin of a second strain of S. epidermidis responsible for subsequent episodes of staphylococcal bacteraemia. Both the oral mucosa and central venous lines should be considered as potential sources of organisms, including coagulase-negative staphylococci, associated with bacteraemia in immunocompromised patients.


Assuntos
Bacteriemia/microbiologia , Transplante de Medula Óssea , Infecções Estafilocócicas/microbiologia , Staphylococcus epidermidis/isolamento & purificação , Infecções Estreptocócicas/microbiologia , Streptococcus oralis/isolamento & purificação , Adolescente , DNA Bacteriano/análise , Eletroforese em Gel de Campo Pulsado , Humanos , Hospedeiro Imunocomprometido , Masculino , Testes de Sensibilidade Microbiana , Mucosa Bucal/microbiologia , Staphylococcus epidermidis/classificação , Staphylococcus epidermidis/efeitos dos fármacos , Staphylococcus epidermidis/genética , Streptococcus oralis/classificação , Streptococcus oralis/efeitos dos fármacos , Streptococcus oralis/genética
18.
J Med Microbiol ; 44(3): 203-10, 1996 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8636938

RESUMO

The spread of Burkholderia cepacia among cystic fibrosis (CF) patients in the UK prompted an investigation into whether an epidemic strain was responsible. A total of 366 B. cepacia isolates from 178 CF patients in 17 centres was examined by ribotyping and pulsed-field gel electrophoresis (PFGE). Associations were also sought between antibiotic resistance and strain type. More than 50 ribotype patterns were found but one, termed ribotype 1, was identified from 68 patients in eight centres. One centre had a single patient with this type while, in others, most or all patients harboured this organism. Small clusters of apparent cross-colonisation within centres were also evident for some other ribotypes. PFGE confirmed that ribotype 1 isolates were genetically similar. Ribotype 1 isolates were not markedly more resistant to antimicrobial agents than were other isolates, and the MICs of individual antibiotics were no more tightly clustered for ribotype 1 isolates than for others. Most isolates were resistant to ciprofloxacin, amikacin, gentamicin, tobramycin, carbenicillin, cefuroxime, cefotaxime, imipenem, biapenem, chloramphenicol, tetracycline, trimethoprim and sulphamethoxazole, but > or = 77% were susceptible to ceftazidime, piperacillin, piperacillin/ tazobactam and meropenem. We conclude that numerous strains of B. cepacia colonise CF patients in the UK and Ireland but that one epidemic strain has spread in at least eight centres. Isolates of this strain appear homogenous in total genomic profile but very variable in antibiotic susceptibility.


Assuntos
Infecções por Burkholderia/microbiologia , Burkholderia cepacia/classificação , Fibrose Cística/microbiologia , Técnicas de Tipagem Bacteriana , Infecções por Burkholderia/complicações , Infecções por Burkholderia/epidemiologia , Burkholderia cepacia/efeitos dos fármacos , Burkholderia cepacia/genética , Infecção Hospitalar , Fibrose Cística/complicações , Impressões Digitais de DNA , DNA Bacteriano/classificação , DNA Ribossômico/classificação , Eletroforese em Gel de Campo Pulsado , Variação Genética , Humanos , Irlanda/epidemiologia , Testes de Sensibilidade Microbiana , Reino Unido/epidemiologia
19.
J Hosp Infect ; 47(3): 188-92, 2001 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11247678

RESUMO

From September 1994 to May 1996, a strain of multi-resistant Chryseobacterium (Flavobacterium) meningosepticum was isolated from eight neonates on a neonatal intensive care unit. The strain was resistant to ampicillin, ceftazidime, imipenem, gentamicin, ciprofloxacin and trimethoprim-sulphamethoxazole, susceptible to piperacillin and amikacin, and had variable susceptibility to rifampicin and vancomycin. Two neonates were infected (one had pneumonia and one septicaemia and meningitis); the remaining six neonates were colonized in the respiratory secretions. Two cases occurred that could not be explained by cross-infection during the outbreak. Environmental screening recovered C. meningosepticum from sink taps. Pulsed-field gel electrophoresis of chromosomal macrorestriction digests of patient and environmental isolates showed them to be representatives of a single strain. The outbreak was controlled after staff were required to use an alcoholic handrub after washing hands, and toiletting of babies was done with sterile water instead of tap-water. Repair and chlorination of the water-tanks and changing the sink-taps resolves the outbreak.


Assuntos
Infecção Hospitalar/microbiologia , Resistência Microbiana a Medicamentos , Resistência a Múltiplos Medicamentos , Flavobacterium/isolamento & purificação , Infecções por Bactérias Gram-Negativas/imunologia , Unidades de Terapia Intensiva Neonatal , Microbiologia da Água , Infecção Hospitalar/prevenção & controle , Surtos de Doenças , Reservatórios de Doenças , Flavobacterium/efeitos dos fármacos , Flavobacterium/patogenicidade , Infecções por Bactérias Gram-Negativas/tratamento farmacológico , Humanos , Recém-Nascido , Recém-Nascido Prematuro , Controle de Infecções , Transmissão de Doença Infecciosa do Profissional para o Paciente , Londres , Polimorfismo de Fragmento de Restrição , Engenharia Sanitária
20.
J Hosp Infect ; 28(4): 273-86, 1994 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-7897189

RESUMO

After uneventful use of cefotaxime and ceftazidime as first line therapy for three years in our neonatal intensive care unit we isolated cephalosporin-resistant Enterobacter cloacae (CREC) strains which caused clusters of cases or colonization and/or serious neonatal infection. By using two or more typing methods, at least five different strains with similar patterns of antimicrobial sensitivities were identified. The results of a case-control study did not support the notion that the use of third generation cephalosporins was associated with colonization and infection by CREC. The outbreak was brought under control by interrupting the transmission of the epidemic strain D, by measures such as cohort nursing, diligent handwashing before and after procedures, and thorough environmental cleaning as well as by decontamination with glutaraldehyde after dismantling of the blood gas analyser believed to have acted as a persistent reservoir. Our experience highlights the danger of inadequate supervision and maintenance of equipment used for near-patient testing and the need to monitor such equipment not only in terms of its calibration and analytical performance but also microbiologically.


Assuntos
Cefalosporinas/uso terapêutico , Infecção Hospitalar/epidemiologia , Surtos de Doenças , Enterobacter cloacae/isolamento & purificação , Infecções por Enterobacteriaceae/epidemiologia , Unidades de Terapia Intensiva Neonatal , Gasometria/instrumentação , Estudos de Casos e Controles , Resistência às Cefalosporinas , Contagem de Colônia Microbiana , Reservatórios de Doenças , Infecções por Enterobacteriaceae/tratamento farmacológico , Contaminação de Equipamentos , Humanos , Recém-Nascido , Controle de Infecções/métodos , Londres/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA